logo

For the Inventor, By the Inventor

London, United Kingdom

Tusk Therapeutics Ltd.

Calculating rank
USPTO Granted Patents = 12


Forward Citations = 30

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Sergio Quezada (12 out of 13 patents)

silverMedal Anne Goubier (12 out of 20 patents)

bronzeMedal Beatriz Goyenechea Corzo (12 out of 20 patents)

4.  Josephine Salimu (12 out of 20 patents)

5.  Kevin Moulder (12 out of 20 patents)

6.  Pascal Merchiers (12 out of 20 patents)

7.  Bianka Prinz (8 out of 62 patents)

8.  Mark Brown (8 out of 8 patents)

9.  James Geoghegan (8 out of 8 patents)

10.  Karl Peggs (1 out of 2 patents)

11.  Frederick Arce Vargas (1 out of 1 patent)

12.  Isabelle Solomon (1 out of 1 patent)

13.  Joseph Mabbitt (0 patent)

14.  Stephanie Hopley (0 patent)


12 patents:

1. 11919960 - Anti-CD25 antibody agents (2024-03-05),
2. 11879014 - Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody (2024-01-23),
3. 11873341 - Anti-CD25 for tumour specific cell depletion (2024-01-16),
4. 11851494 - Anti-CD25 for tumour specific cell depletion (2023-12-26),
5. 11814434 - Anti-CD25 for tumour specific cell depletion (2023-11-14),
6. 11802161 - Anti-CD25 for tumour specific cell depletion (2023-10-31),
7. 11802160 - Anti-CD25 antibody agents (2023-10-31),
8. 11787866 - Anti-CD25 antibody agents (2023-10-17),
9. 11697688 - Anti-CD25 for tumour specific cell depletion (2023-07-11),
10. 10752691 - Anti-CD25 antibody agents (2020-08-25),
11. 10745485 - Anti-CD25 antibody agents (2020-08-18),
12. 10738125 - Anti-CD25 antibody agents (2020-08-11),
Company Overview
Tusk Therapeutics Ltd. is a biotechnology company based in London, specializing in the development of innovative therapies for cancer and autoimmune diseases. The organization focuses on harnessing the power of the immune system to create targeted treatments that enhance patient outcomes. With a commitment to advancing therapeutic solutions, Tusk Therapeutics is engaged in cutting-edge research and development, aiming to address unmet medical needs in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

12 Patents

#286 in London

#1,463 in United Kingdom

#48,334 in the World

London, GB
London, United Kingdom

Tusk Therapeutics Ltd.

Forward Citations = 30

12 inventors:

goldMedal Sergio Quezada (12 out of 13 patents)

silverMedal Anne Goubier (12 out of 20 patents)

bronzeMedal Beatriz Goyenechea Corzo (12 out of 20 patents)

4.  Josephine Salimu (12 out of 20 patents)

5.  Kevin Moulder (12 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tusk Therapeutics Ltd.. Retrieved from https://idiyas.com/company/tusk-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…